MedPath

Cohort of Premature Newborns for Charaterization of the Digestive Microbiota in Ulcerative Necrotizing Enterocolitis in Premature Infants

Not Applicable
Recruiting
Conditions
Necrotizing Enterocolitis
Premature Birth
Interventions
Biological: premature newborns developing a NEC
Biological: premature newborns without NEC
Registration Number
NCT04972734
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Compare the bacterial digestive microbiota during the stay in neonatal intensive care between a group of premature newborns developing a NEC (necrotizing enterocolitis) and a group of newborns free from NEC.

Detailed Description

Monitoring of a cohort of premature newborns with constitution of a collection of biological samples.

follow-up of newborns from birth up to 37 weeks of amenorrhea. The medical care of children will not be affected by their participation in the research.

* Sampling of amniotic fluid at the time of rupture of the water bag

* Sampling of the blood contained in the umbilical cord after clamping and section of the cord

* Sampling of meconium during the first 24 hours of life in intensive care / neonatal / maternity ward

* Collection of a daily stool sample until the end of hospitalization and when a NEC occurs

* Sampling of gastric residues during an episode of NEC

* Taking a daily sample of the newborn's enteral food

* Sampling of 500 µL of additional blood weekly during the punctures made for the treatment

* Daily statement of constants

* Record of all complications related to prematurity (HIV, bronchodysplastic, sepsis)

* Blood analysis: CBC, platelets and CRP (data analyzed as part of the treatment). Specific analyzes for research will assess: the level of tryptase, IL4 and TLR4. The samples will be stored and analyzed in the immunology laboratory of the CHU Clermont Ferrand (Pr B. Evrard)

* Analysis of the meconium sample and each stool emitted during hospitalization, and during an episode of ECUN

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • born prematurely < 37 weeks of amenorrhea at the maternity ward of the CHU
  • affiliated with a social security regime
  • the holders of parental authority are able to give an informed consent to participate in the research
Exclusion Criteria
  • fetal pathology
  • newborns whose holders of parental authority are under guardianship or under the age of 18
  • refusal of participation by holders of parental authority

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NECpremature newborns developing a NECpremature newborns developing a NEC
Healthy controlpremature newborns without NECpremature newborns without NEC
Primary Outcome Measures
NameTimeMethod
comparison of volatolomics results of the gut microbiotaImmediatly after the intervention

Characterization of the gut microbiota using a capture method by hybridization of the gene encoding 16S rRNA

comparison of microbiological results of the gut microbiotaImmediatly after the intervention

Characterization of the gut microbiota using a capture method by hybridization of the gene encoding 16S rRNA

Secondary Outcome Measures
NameTimeMethod
TryptasemiaDay 1, Day 3, Immediatly after the intervention

measurement of blood tryptasemia

Fungal microbiotaImmediatly after the intervention

Comparison of the fungal microbiota on 10 NECS and 10 healthy babies

environmental xenobioticsDay 1

measurement of titane and silicia levels in placental and meconium assays

Milk protein compositiondaily for 12 weekd

milk protein determination

Milk lipid compositiondaily for 12 weekd

milk lipid determination

Trial Locations

Locations (1)

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath